| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |